« Back
Home /
ENMD-2076 100mg

ENMD-2076 100mg

Item no.	A10352-100
Manufacturer	Adooq
CASRN	934353-76-1, 1291074-87-7 (Tartrate)
Amount	100 mg
Quantity options	1 mg 10 mg 100 mg 10mM x 1mL in DMSO 2 mg 25 mg 5 mg 50 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)/C=C/C4=CC=CC=C4
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	ENMD2076, ENMD 2076
Similar products	ENMD-2076
Available
Storage Conditions	2 years at -20C
Molecular Weight	375, 5
Chemical Name	(E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine
Description	ENMD-2076 is a novel, orally-active antimitotic and antiangiogenic molecule inhibits Aurora A as well as tyrosine kinases that drive tumor vascularization, including VEGFR2 (KDR), PDGFR and the FGF receptors.
Solubilty	DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 8/21/2025

Express Delivery: Save 1 days

Compare

Add to wishlist

Get an offer